Research and Markets: Drug Discovery for Nervous System Diseases Analysed in Latest Publication
Posted on: Monday, 22 August 2005, 12:00 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c23052) has announced the addition of Drug Discovery for Nervous System Diseases to their offering.
The neurosciences have been an especially difficult field for drug discovery. Because of the huge complexity of the nervous system and poor understanding of most psychiatric and neurological diseases, most drugs currently available are the result of chance observations rather than a truly comprehensive approach. However, this situation has begun to change. Enormous progress in molecular biology has yielded breakthrough discoveries of the causes of nervous system diseases, opening the door for better-targeted and entirely novel therapies.
Reflecting these recent advances, Drug Discovery for Nervous System Diseases presents the latest techniques and approaches for drug discovery, organizing them according to diseases rather than classes of drugs or drug targets, as past books have done. Written with optimistic anticipation of great progress still to come, this text provides both a guide to present realities and a look to future possibilities in this burgeoning field.
Coverage in Drug Discovery for Nervous System Diseases includes: Fundamentals of drug discovery-receptors, target selection, and drug development, Schizophrenia, Depression, Anxiety disorders. Alzheimers disease, Parkinsons disease, Ischemic stroke, brain, and spinal cord injury Other neurodegenerative diseases Sleep disorders, Epilepsy and Pain. This practical handbook features a uniform presentation for each chapter, with a brief description of existing drugs leading to recent molecular biological and genetic findings, translational research and the interface to clinical trials, and finally an outlook on future drug targets. Rich illustrations-schematic diagrams and tables-provide a dynamic visual experience throughout the text. A unique and up-to-date guide to a field currently undergoing a major growth spurt, Drug Discovery for Nervous System Diseases offers both practitioners and advanced students an unparalleled resource.
1. Introduction.
2. Drug Receptors and the Fundamentals of Pharmacology.
3. Drug Discovery.
4. Drug Target Selection for Nervous System Diseases.
5. From Drug Target to Drug, Neuroscience Specific Problems.
6. Schizophrenia.
7. Depression.
8. Anxiety Disorders.
9. Alzheimers Disease.
10. Parkinsons Disease.
11. Ischemic Stroke, Brain and Spinal Cord Injury.
12. Other Neurodegenerative Diseases.
13. Sleep Disorders.
14. Epilepsy.
15. Pain.
For more information visit http://www.researchandmarkets.com/reports/c23052
Source: Business Wire
Related Articles
- Nanoparticles Used To Target Drugs
- Light Sciences Oncology Expands Development of Novel Targeted Drug Aptocine(TM) For Prostate Conditions With Start-Up of Phase 2 BPH Trial
- This Major Strategic Analysis Provides a Detailed Insight Into the Current and Future Market for Targeted Drug Delivery Technology
- ``Musculo-Skeletal-Disorders - Muscle Pain Drug Pipeline Report'' Contains Detailed Information on the Current Drug Pipeline
- FDA OKs Drug to Treat Rare Blood Disorder
- Discovery Close to OK on RDS Drug
- Is an Oral Disease-Modifying Drug on the Horizon?
- Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates
- "We Just Feel so Blessed" BR Boy First to Get New Drug Treatment for Rare Genetic Disorder
 |
 |
User Comments (0)
RSS Feeds